Table of Contents Author Guidelines Submit a Manuscript
Journal of Spectroscopy
Volume 2014, Article ID 917234, 12 pages
http://dx.doi.org/10.1155/2014/917234
Research Article

Kinetic Spectrophotometric Determination of Gemifloxacin Mesylate and Moxifloxacin Hydrochloride in Pharmaceutical Preparations Using 4-Chloro-7-nitrobenzo-2-oxa-1,3-diazole

Chemistry Department, Faculty of Science, Zagazig University, Zagazig 44519, Egypt

Received 4 September 2013; Accepted 3 December 2013; Published 3 February 2014

Academic Editor: Adam F. Lee

Copyright © 2014 Mohammed G. Abdel Wahed et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. C. Sweetman, Martindale: The Complete Drug Reference, Pharmaceutical Press, London, UK, 35th edition, 2011.
  2. M. J. O'Neil, The Merck Index: An Encyclopedia of Chemicals, Drugs and Biologicals, Merck, New York, NY, USA, 14th edition, 2006.
  3. B. M. H. Al-Hadiya, A. A. Khady, and G. A. E. Mostafa, “Validated liquid chromatographic-fluorescence method for the quantitation of gemifloxacin in human plasma,” Talanta, vol. 83, no. 1, pp. 110–116, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. A. R. Rote and S. P. Pingle, “Reverse phase-HPLC and HPTLC methods for determination of gemifloxacin mesylate in human plasma,” Journal of Chromatography B, vol. 877, no. 29, pp. 3719–3723, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Sultana, M. S. Arayne, M. Akhtar, S. Shamim, S. Gul, and M. M. Khan, “High-performance liquid chromatography assay for moxifloxacin in bulk, pharmaceutical formulations and serum: application to in-vitro metal interactions,” Journal of the Chinese Chemical Society, vol. 57, no. 4 A, pp. 708–717, 2010. View at Google Scholar · View at Scopus
  6. M. Y. Salem, N. M. El-Guindi, H. K. Mikael, and L. E.-S. Abd-El-Fattah, “Stability indicating methods for the determination of some fluoroquinolones in the presence of their decarboxylated degradates,” Chemical and Pharmaceutical Bulletin, vol. 54, no. 12, pp. 1625–1632, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. A. F. Faria, M. V. N. de Souza, M. V. de Almeida, and M. A. L. de Oliveira, “Simultaneous separation of five fluoroquinolone antibiotics by capillary zone electrophoresis,” Analytica Chimica Acta, vol. 579, no. 2, pp. 185–192, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. A. A. Elbashir, B. Saad, A. S. M. Ali, K. M. M. Al-Azzam, and H. Y. Aboul-Enein, “Validated stability indicating assay of gemifloxacin and lomefloxacin in tablet formulations by capillary electrophoresis,” Journal of Liquid Chromatography and Related Technologies, vol. 31, no. 10, pp. 1465–1477, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. N. T. Abdel Ghani, M. A. El-Ries, and M. A. El-Shall, “Validated polarographic methods for the determination of certain antibacterial drugs,” Analytical Sciences, vol. 23, no. 9, pp. 1053–1058, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. A.-E. Radi, T. Wahdan, Z. Anwar, and H. Mostafa, “Electrochemical and spectroscopic studies on the interaction of gatifloxacin, moxifloxacin and sparfloxacin with DNA and their analytical applications,” Electroanalysis, vol. 22, no. 22, pp. 2665–2671, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. A.-E. Radi, T. Wahdan, Z. Anwar, and H. Mostafa, “Electrochemical determination of gatifloxacin, moxifloxacin and sparfloxacin fluoroquinolonic antibiotics on glassy carbon electrode in pharmaceutical formulations,” Drug Testing and Analysis, vol. 2, no. 8, pp. 397–400, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. S. M. Al-Ghannam, “Atomic absorption spectroscopic, conductometric and colorimetric methods for determination of some fluoroquinolone antibacterials using ammonium reineckate,” Spectrochimica Acta A, vol. 69, no. 4, pp. 1188–1194, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Salem, “Spectrofluorimetric, atomic absorption spectrometric and spectrophotometric determination of some fluoroquinolones,” American Journal of Applied Sciences, vol. 2, no. 3, pp. 719–729, 2005. View at Google Scholar
  14. S. E. K. Tekkeli and A. Önal, “Spectrofluorimetric methods for the determination of gemifloxacin in tablets and spiked plasma samples,” Journal of Fluorescence, vol. 21, no. 3, pp. 1001–1007, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. S. T. Ulu, “Rapid and sensitive spectrofluorimetric determination of enrofloxacin, levofloxacin and ofloxacin with 2,3,5,6-tetrachloro-p-benzoquinone,” Spectrochimica Acta A, vol. 72, no. 5, pp. 1038–1042, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Shah, R. Rasul Jan, I. Inayatullah, and N. Naeem Khan, “Micellar-enhanced spectrofluorometric quantification of moxifloxacin in pharmaceutical formulations, human urine and plasma samples,” African Journal of Pharmacy and Pharmacology, vol. 5, no. 5, pp. 616–624, 2011. View at Google Scholar · View at Scopus
  17. S. B. Wankhede, A. M. Mahajan, and S. S. Chitlange, “Simultaneous spectrophotometric estimation of gemifloxacin mesylate and ambroxol hydrochloride in tablets,” Der Pharma Chemica, vol. 3, no. 1, pp. 269–273, 2011. View at Google Scholar · View at Scopus
  18. R. I. EL-Bagary, N. F. Abo-talib, and M. B. N. Eldin, “Validated stability indicating assay of gemifloxacin by different chromatographic and spectrophotometric methods of analysis,” Journal of Chemical and Pharmaceutical Research, vol. 3, no. 6, pp. 562–570, 2011. View at Google Scholar
  19. D. C. Charan and S. Satyabrata, “Simple and rapid spectrophotometric estimation of gemifloxacin mesylate in bulk and tablet formulations,” International Journal of PharmTech Research, vol. 3, no. 1, pp. 133–135, 2011. View at Google Scholar · View at Scopus
  20. K. Hajera, “Development and validation of a dissolution test with spectrophotometric analysis for gemifloxacin in tablet dosage form,” International Journal of Research in Pharmaceutical and Biomedical Sciences, vol. 3, no. 1, pp. 90–95, 2012. View at Google Scholar
  21. S. V. V. Dhanu Radha, K. M. C. Apparao, and K. Ramakrishna, “New visible spectrometric determination of gemifloxacin in its pure form,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 4, pp. 618–621, 2012. View at Google Scholar
  22. V. Balaji, S. Poongothai, B. Madhavi et al., “Development and validation of adissolution test with spectrophotometric analysis for gemifloxacin in tablet dosage form,” Pharma Science Monitor, vol. 2, no. 2, pp. S132–S145, 2010. View at Google Scholar
  23. M. V. Krishna and D. G. Sankar, “Utility of σ and π-acceptors for the spectrophotometric determination of gemifloxacin mesylate in pharmaceutical formulations,” E-Journal of Chemistry, vol. 5, no. 3, pp. 493–498, 2008. View at Google Scholar · View at Scopus
  24. M. V. Krishna and D. G. Sankar, “Spectrophotometric determination of gemifloxacin mesylate in pharmaceutical formulations through ion-pair complex formation,” E-Journal of Chemistry, vol. 5, no. 3, pp. 515–520, 2008. View at Google Scholar · View at Scopus
  25. S. Ganapathy, G. V. H. Raju, D. G. Sankar, and P. Y. Naidu, “Spectrophotometric determination of gemifloxacin in bulk and pharmaceutical formulation,” Asian Journal of Chemistry, vol. 21, no. 8, pp. 6508–6512, 2009. View at Google Scholar · View at Scopus
  26. Z. Y. Al Shoaibi and A. A. Gouda, “Spectrophotometric methods for the determination of gemifloxacin mesylate in pure form and pharmaceutical formulations,” Analytical Chemistry, vol. 9, 2010. View at Google Scholar
  27. M. Sugumaran, V. Meganathan, and T. Vetrichelvan, “Spectrophotometric method for the determination of Gemifloxacin mesylate in bulk and pharmaceutical formulations,” Biosciences Biotechnology Research Asia, vol. 5, no. 1, pp. 495–496, 2008. View at Google Scholar · View at Scopus
  28. D. Madhuri, K. B. Chandrasekhar, N. Devanna, and G. Somasekhar, “Direct and derivative spectrophotometric estimation of gemifloxacin by chelation with palladium(II) ion,” Rasayan Journal of Chemistry, vol. 3, no. 1, pp. 159–165, 2010. View at Google Scholar · View at Scopus
  29. D. M. Dhumal, A. A. Shirkhedkar, and S. J. Surana, “Quantitative determination of moxifloxacin hydrochloride in bulk and ophthalmic solution by UV-spectrophotometry and first order derivative using area under curve,” Der Pharmacia Lettre, vol. 3, no. 3, pp. 453–456, 2011. View at Google Scholar · View at Scopus
  30. M. Misra, A. K. Misra, P. Zope, G. M. Panpalia, and A. K. Dorle, “Simple and validated UV-spectroscopic method for estimation of moxifloxacin.HCL in bulk and formulation,” Journal of Global Pharma Technology, vol. 2, no. 6, pp. 21–27, 2010. View at Google Scholar · View at Scopus
  31. P. U. Patel, B. N. Suhagia, and M. M. Patel, “Spectrophotometric methods for estimation of moxifloxacin in pharmaceutical formulations,” Indian Drugs, vol. 42, no. 10, pp. 654–657, 2005. View at Google Scholar · View at Scopus
  32. A. Cirić, R. Jelić, L. Joksović, M. Jelikić-Stankov, and P. Djurdjević, “Determination of moxifloxacin in human plasma by derivative UV spectrophotometry in a micellar medium,” Canadian Journal of Analytical Science and Spectroscopy, vol. 52, no. 6, pp. 343–350, 2007. View at Google Scholar
  33. S. K. Motwani, S. Chopra, F. J. Ahmad, and R. K. Khar, “Validated spectrophotometric methods for the estimation of moxifloxacin in bulk and pharmaceutical formulations,” Spectrochimica Acta A, vol. 68, no. 2, pp. 250–256, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. M. A. Sultan, “New, simple and validated kinetics spectrophotometric method for determination of moxifloxacine in its pharmaceutical formulations,” Arabian Journal of Chemistry, vol. 2, no. 2, pp. 79–85, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. D. R. Chaple and K. P. Bhusari, “Spectrophotometric estimation of fluroquinolones as ion-pairs with bromocresol green in bulk and pharmaceutical dosage form,” Asian Journal of Chemistry, vol. 22, no. 4, pp. 2593–2598, 2010. View at Google Scholar · View at Scopus
  36. L. M. Abdellaziz and M. M. Hosny, “Development and validation of spectrophotometric, atomic absorption and kinetic methods for determination of moxifloxacin hydrochloride,” Analytical Chemistry Insights, vol. 6, no. 1, pp. 67–78, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. D. Pérez-Bendito, A. Gómez-Hens, and M. Silva, “Advances in drug analysis by kinetic methods,” Journal of Pharmaceutical and Biomedical Analysis, vol. 14, no. 8–10, pp. 917–930, 1996. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Job, Spectrochemical Methods of Analysis, Wiley Intersience, New York, NY, USA, 1971.
  39. F. Wilkinson and V. Nostrand, Chemical Kinetics and Reaction Mechanism, Rheihold Company, New York, NY, USA, 1980.
  40. D. Pérez-Bendito and M. Silva, Kinetic Methods in Analytical Chemistry, John Wiley and Sons, New York, NY, USA, 1988.
  41. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonized Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology, Q2(R 1), Complementary Guideline on Methodology dated 06 November 1996, ICH, London, UK, 2005.
  42. J. N. Miller and J. C. Miller, Statistics and Chemometrics for Analytical Chemistry, Prentice Hall, England, UK, 5th edition, 2005.